BAYTRIL 10% ORAL SOLUTION

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv ingrediens:

ENROFLOXACIN

Tilgjengelig fra:

Bayer Limited

ATC-kode:

QJ01MA90

INN (International Name):

ENROFLOXACIN

Dosering :

10 Mg/Ml

Legemiddelform:

Oral Solution

Resept typen:

POM

Terapeutisk gruppe:

Fowl - Chicken, Fowl - Turkey, Rabbits

Terapeutisk område:

Enrofloxacin

Indikasjoner:

Antibacterial

Autorisasjon status:

Authorised

Autorisasjon dato:

1988-10-01

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 10% Oral Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml of Baytril 10% Oral Solution contains:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for use in drinking water.
Clear yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chicken, turkey and rabbit.
Active Substance
Enrofloxacin
100 mg
Excipient(s)
Benzyl alcohol
14 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_6_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by the following bacteria susceptible
to enrofloxacin:
CHICKENS
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Avibacterium paragallinarum,_
_Pasteurella multocida,_
_Escherichia coli._
TURKEYS
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Pasteurella multocida,_
_Escherichia coli._
RABBITS
For the treatment infectious diseases due to_ Pasteurella multocida_
and bacterial enteritis due to infection with_ E.coli._
Enrofloxacin should be used where clinical experience, supported where
possible by sensitivity testing of the causal
organism, indicates enrofloxacin as the active substance of choice.
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not use when resistance/ cross-resistance to (fluoro)quinolones is
known to occur in the flock int